Hong Kong unemployment rate unchanged
- By Paul Arkwright
- on 22 February 2022
According to the latest labour force statistics from the Census and Statistics Department (C&SD), Hong Kong’s employment rate as of the end of January...
Read moreFewer women in U.S. workforce
- By Paul Arkwright
- on 21 February 2022
New data released by the U.S. Federal Government has shown that women disproportionately fall behind men when it comes to re-entering the workforce post-pandemic....
Read moreHong Kong’s shifting workforce trends
- By Paul Arkwright
- on 18 February 2022
As more enterprises embrace hybrid models of working, they are witnessing how it can empower businesses and employees to be more productive whilst...
Read moreTrip.com embraces hybrid work
- By Paul Arkwright
- on 17 February 2022
Travel service provider Trip.com Group has announced that it will implement a global hybrid work model, giving employees the option to work remotely from...
Read moreModerna announces APAC expansion
- By Paul Arkwright
- on 16 February 2022
Moderna announced yesterday its expansion plans in the Asia Pacific region with four new subsidiaries to be established in Malaysia, Taiwan, Singapore and Hong...
Read moreAPAC interest in compressed 4-day week higher
- By Paul Arkwright
- on 15 February 2022
The idea of a 4-day workweek has been a hot topic of discussion for businesses across the globe, with a few notable companies making...
Read moreThird of APAC workers facing burnout
- By Paul Arkwright
- on 14 February 2022
A study by Instant Offices has revealed that a third of workers across Asia including Australia, Hong Kong, Japan, Malaysia and Singapore have felt...
Read moreNumber of women on boards in Asia up
- By Paul Arkwright
- on 11 February 2022
Deloitte’s 7th iteration of its Women in the boardroom: A global perspective report has highlighted an average of 11.7% of board seats in Asia...
Read moreMSKs most costly for multinationals
- By Paul Arkwright
- on 10 February 2022
Musculoskeletal conditions were found to be the costliest disease for multinationals. Almost half (48%) of the total amount paid under the MSK category was...
Read more